Arcellx (ACLX) Interest & Investment Income (2021 - 2025)
Arcellx's (ACLX) quarterly Interest & Investment Income came in at -$18.6 million in Q4 2025, down 345.6% year-on-year from $7.6 million in Q4 2024, and down 410.66% quarter-over-quarter from $6.0 million in Q3 2025.
Arcellx (ACLX) Interest & Investment Income (2021 - 2025) Analysis & Trends
Arcellx's Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$18.6 million for Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 345.6% year-over-year to -$18.6 million in Q4 2025; TTM through Dec 2025 was -$13.1 million, a 246.32% decrease from a year earlier, with the FY2025 full-year figure at -$5000.0, down 100.02% from the prior year.
- Interest & Investment Income fell to -$18.6 million in Q4 2025 per ACLX's latest filing, from $6.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $23.5 million in Q4 2023 and bottomed at -$18.6 million in Q4 2025.
- The 5-year median for Interest & Investment Income is -$41000.0 (2022), against an average of $1.3 million.
- Biggest YoY gain for Interest & Investment Income was 31293.33% in 2022; the steepest drop was 2640.0% in 2022.
- Year by year, Interest & Investment Income stood at -$15000.0 in 2021, then soared by 31293.33% to $4.7 million in 2022, then jumped by 403.08% to $23.5 million in 2023, then sank by 67.79% to $7.6 million in 2024, then slumped by 345.6% to -$18.6 million in 2025.
- Per Business Quant, the three latest ACLX Interest & Investment Income figures stand at -$18.6 million (Q4 2025), $6.0 million (Q3 2025), and -$246000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -18.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.62 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | -246,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | 23.54 Mn |
| Sep 30, 2023 | -58,000.00 |
| Jun 30, 2023 | -93,000.00 |
| Mar 31, 2023 | 307,000.00 |
| Dec 31, 2022 | 4.68 Mn |
| Sep 30, 2022 | -137,000.00 |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | -24,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Sep 30, 2021 | -5,000.00 |